613 related articles for article (PubMed ID: 2578877)
1. Two mouse monoclonal antibodies detecting two different epitopes of an activated lymphocyte antigen on adult T-cell leukemia cells.
Ueda R; Nishida K; Koide Y; Tsuge I; Seto M; Yoshida M; Miyoshi I; Ota K; Takahashi T
Cancer Res; 1985 Mar; 45(3):1314-9. PubMed ID: 2578877
[TBL] [Abstract][Full Text] [Related]
2. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
Yodoi J; Teshigawara K; Nikaido T; Fukui K; Noma T; Honjo T; Takigawa M; Sasaki M; Minato N; Tsudo M
J Immunol; 1985 Mar; 134(3):1623-30. PubMed ID: 2578514
[TBL] [Abstract][Full Text] [Related]
3. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
Howard DR; Eaves AC; Takei F
Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
5. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells.
Takeuchi T; Barcos MP; Seon BK
Cancer Res; 1991 Jun; 51(11):2985-93. PubMed ID: 1709587
[TBL] [Abstract][Full Text] [Related]
7. Human T cell lines differing in phenotype and specificity are reactive with the same anti-idiotypic antibody.
Borst J; Boylston AW; de Vries JE; Spits H
J Immunol; 1986 Jan; 136(2):601-8. PubMed ID: 2416817
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC
Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687
[TBL] [Abstract][Full Text] [Related]
10. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
11. Individual epitopes of an 85,000 MW membrane adherence molecule are variably expressed on cells of different lineage.
Schulz TF; Vogetseder W; Mitterer M; Böck G; Johnson JP; Dierich MP
Immunology; 1988 Aug; 64(4):581-6. PubMed ID: 2459048
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibodies reactive with human myelomonocytic leukemia cells.
Posner MR; Santos DJ; Elboim HS; Tumber MB; Frackelton AR
Cancer Res; 1989 Apr; 49(7):1665-70. PubMed ID: 2924315
[TBL] [Abstract][Full Text] [Related]
13. Expression of a T cell receptor-like molecule on normal and malignant murine T cells detected by rat monoclonal antibodies to nonclonotypic determinants.
Chan PY; Takei F
J Immunol; 1986 Feb; 136(4):1346-53. PubMed ID: 2418112
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
15. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
16. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel T cell surface disulfide-bonded dimer distinct from the alpha/beta antigen receptor.
Nagasawa R; Gross J; Kanagawa O; Townsend K; Lanier LL; Chiller J; Allison JP
J Immunol; 1987 Feb; 138(3):815-24. PubMed ID: 2433330
[TBL] [Abstract][Full Text] [Related]
18. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]